BTCY - Biotricity: Poised For Disruptive And Explosive Growth

• BTCY is a possible industry disruptor with triple-digit growth rates, but few investors know about them.
• The business approach of BTCY benefits both physicians and patients while lowering overall medical expenses.
• BTCY management is guiding for triple-digit growth for the next two years on their initial medical device alone - future devices and technology will likely add significantly to those already outstanding numbers.
• While BTCY will need additional cash in about 18 months to continue funding its explosive growth, they believe they have investors who will step up when asked.
• Based on industry peers' valuation metrics, BTCY could easily quadruple if they simply meet management guidance, with further upside on newer devices and technology in the pipeline.

For further details see: